Related Experiment Video
Updated: Aug 5, 2026

07:46
Colonization with Murine pks+ Escherichia coli under Non-Inflammatory Conditions
Published on: March 10, 2026
The link between microplastics and colorectal cancer
Anisha Lynch-Godrei1,2,3, Christopher Leung4,5,6
1Department of Medicine, The University of Melbourne, Parkville, VIC, 3010, Australia.
Cancer Metastasis Reviews
|July 31, 2026
Summary
Microplastics and nanoplastics (MNPLs) accumulate in the body and are found in colorectal tumors. Exposure to MNPLs may promote colorectal cancer development, especially with a compromised gut barrier.
Area of Science:
- Environmental Health
- Oncology
- Toxicology
Background:
- Microplastics and nanoplastics (MNPLs) are pervasive environmental contaminants.
- Accumulation of MNPLs in human tissues is documented, with potential toxic effects.
- The link between MNPLs and colorectal cancer (CRC) tumorigenesis requires further investigation.
Purpose of the Study:
- To evaluate the association between MNPLs and colorectal cancer development.
- To synthesize current evidence on MNPLs in CRC tissues and patient samples.
- To explore the mechanistic pathways by which MNPLs might influence CRC.
Main Methods:
- A comprehensive literature review was performed using Ovid MEDLINE and PubMed.
- Search strategy focused on MeSH terms "colorectal carcinoma" and "microplastic".
- Fourteen relevant studies were selected from an initial pool of forty-one.
Main Results:
- MNPLs detected in human colorectal tumors and at higher concentrations in CRC patient feces.
- Animal studies showed increased tumor burden and gut dysbiosis following MNPL exposure.
- In vitro studies indicated MNPLs induce reactive oxygen species (ROS) production in cells.
Conclusions:
- While direct causation of CRC by MNPLs is unproven, evidence suggests MNPLs can drive tumorigenic molecular changes.
- Compromised gastrointestinal barrier function, common in conditions like IBD, may increase vulnerability to MNPLs.
- Populations with existing gut barrier disruptions may be at higher risk for MNPL-associated CRC development.
Related Concept Videos
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...

